EBS Emergent Biosolutions Inc

Emergent BioSolutions Inc. (NYSE:EBS) will host a conference call on Thursday, May 3, 2018 at 5:00 pm (Eastern Time) to discuss the financial results for the first quarter of 2018, recent business developments, revenue guidance for the second quarter of 2018, and revenue and net income guidance for full year 2018.

This conference call can be accessed live by telephone or by webcast:

Live Teleconference Information:Dial in number: (855) 766-6521International dial in: (262) 912-6157Conference ID: 93329114

Live Webcast Information:Visit https://edge.media-server.com/m6/p/gyy8ca3t for the live webcast feed.

A replay of the call can be accessed on Emergent’s website emergentbiosolutions.com under “Investors.”

About Emergent BioSolutionsEmergent BioSolutions Inc. is a global life sciences company seeking to protect and enhance life by focusing on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. Through our work, we envision protecting and enhancing 50 million lives with our products by 2025. Additional information about the company may be found at www.emergentbiosolutions.com. Follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Investor Contact:Robert G. BurrowsVice President, Investor Relations240-631-3280BurrowsR@ebsi.com

Media Contact:Lynn KiefferVice President, Corporate Communications240-631-3391KiefferL@ebsi.com